Navigation Links
FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
Date:7/16/2009

e "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding regulatory approvals, clinical trials, product performance and competitive offerings. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forwar
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and ... Hospice received the Music & Memory Certification for hospice patients and adult day center ... music not only to patients but also to their families and volunteers. Music & ...
(Date:7/5/2015)... ... ... City Sports, the Boston-based specialty sporting goods retailer, has renewed their partnership ... this summer with ethos, the owner and operator of the Boston Triathlon. , The ... at the North End Greenway. The event will help new triathletes prepare for the ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in 2015, on ... an annual member survey , detailing the most common plastic surgery and minimally ... that raw data down into charts detailing demographic trends and regional preferences. With ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
Breaking Medicine News(10 mins):Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3
... of individuals who suffered from suicidal thoughts and erratic behavior ... ... Mineola, N.Y. (Lexis Nexis) August 5, 2008 - ... personal injury law firm Sanders Viener Grossman LLP, today announced ...
... TRAIT , A new study suggests that people who ... or phenotype that causes them to have poorer asthma ... Researchers from Quebec, Canada compared pulmonary function changes, methacholine ... circumference, and waist-to-hip ratio of 44 obese subjects with ...
... Medicare Regulation Protects, NC Seniors, Access to Quality ... Quality,Nursing Home Care today thanked North Carolina Senators Elizabeth ... bipartisan effort in,Congress to stop the Bush Administration from ... Medicare-funded nursing home care by $5,billion over the next ...
... 4, 2008 - A recent study published in ... (ESAs), a widely used drug to treat anemia, may ... patients. In the study, 323 multiple myeloma patients were ... 1988 to 2007. The investigators reviewed their medical records ...
... 4 Another Eniva nutraceutical moves,to the ... excellent quality and,valid claims. Eniva,s Efacor has ... standards from ConsumerLab.com. ConsumerLab.com,(CL) has long been ... and,quality among nutritional products. CL,s stringent testing ...
... - Total revenue increased 11 percent ... management segment revenue represented 44 percent of total revenue, compared ... - Gross margin rose to 29.4 percent from 28 percent ... share repurchase plan, MINNEAPOLIS, Aug. 4 Health Fitness,Corporation (OTC Bulletin Board: HFIT), a ...
Cached Medicine News:Health News:New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs 2Health News:Chest Journal: August news briefs 2Health News:Dole, Burr Praised for Helping Lead Senate Effort to Stop $21.8 Million North Carolina Medicare Cuts 2Health News:Treatment with anti-anemia drugs may not be safe for multiple myeloma patients 2Health News:Eniva USA Efacor(R) Fish Oil (Non-Fishy Lemon Taste) Receives ConsumerLab.com Seal of Approval 2Health News:HealthFitness Announces 2008 Second Quarter Results 2Health News:HealthFitness Announces 2008 Second Quarter Results 3Health News:HealthFitness Announces 2008 Second Quarter Results 4Health News:HealthFitness Announces 2008 Second Quarter Results 5Health News:HealthFitness Announces 2008 Second Quarter Results 6Health News:HealthFitness Announces 2008 Second Quarter Results 7Health News:HealthFitness Announces 2008 Second Quarter Results 8Health News:HealthFitness Announces 2008 Second Quarter Results 9Health News:HealthFitness Announces 2008 Second Quarter Results 10
(Date:7/6/2015)... -- E-QURE Corp (OTCQB: EQUR), today announced that Ron ... July 9, 2015. DATE: Thursday, July 9, 2015 ... This will be a live, interactive online event ... in real-time - both in the presentation hall as ... are not able to join the event live on ...
(Date:7/6/2015)... , July 6, 2015 Moerae ... developing novel therapeutics that target inflammation and fibrosis, ... , M.D., PhD, as Chief Medical Officer. ... clinical development strategy and programs, which include a ... inflammatory and fibrotic conditions.  Bill is an accomplished ...
(Date:7/6/2015)... July 6, 2015  Impax Laboratories, Inc. (NASDAQ: ... Ph.D. has resigned from the Company,s Board of Directors ... was a co-founder of Impax in 1995 and served ... October 2006 until April 2014. Logo - ... Impax,s President and Chief Executive Officer stated, "We wish ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5
... Osteotech, Inc. (Nasdaq: OSTE ), a leader ... healing, today reported financial results for the third quarter ... of 2009, our focus was on the release of ... FacetLinx(TM) Fusion Technology and Plexur M® Innovative Grafting," said ...
... Calif., Nov. 5 Renee Cobos, MD, a board ... University of California, Irvine, announced today that her patients ... system, which is approved for skin tightening and contouring, ... efficacy and improves patient comfort. , "Thermage has ...
Cached Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2
... The ADVIA 120 Hematology System gets ... right the first time, with a ... systems. Results are more accurate, physicians ... more effective. The ADVIA 120 Hematology ...
The Advia 60 is designed to deliver powerful performance in a small package....
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
... HmX offers three-dimensional VCS ... specificity and efficiency in ... reticulocyte analysis. With its ... dependability, HmX is an ...
Medicine Products: